Evidence map›Paper›PMID 36958851›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2023

Efficacy of the Outsmart HPV Intervention: A Randomized Controlled Trial to Increase HPV Vaccination among Young Gay, Bisexual, and Other Men Who Have Sex with Men.

Paul L Reiter, Amy L Gower, Dale E Kiss, Abigail B Shoben, Mira L Katz, José A Bauermeister, Electra D Paskett, Annie-Laurie McRee

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Primary Care Providers' Perspectives on Barriers and Facilitators to Human Papillomavirus (HPV) Vaccination among Young Adults: A Qualitative Study.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Paul L ReiterCollege of Public Health, The Ohio State University, Columbus, Ohio.ORCID 0000-0001-8252-2600
Amy L GowerDivision of General Pediatrics and Adolescent Health, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota.ORCID 0000-0001-9852-9196
Dale E KissCollege of Public Health, The Ohio State University, Columbus, Ohio.ORCID 0000-0003-0691-4498
Abigail B ShobenCollege of Public Health, The Ohio State University, Columbus, Ohio.ORCID 0000-0001-9347-4755
Mira L KatzCollege of Public Health, The Ohio State University, Columbus, Ohio.ORCID 0000-0001-9791-7592
José A BauermeisterDepartment of Family and Community Health, University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania.ORCID 0000-0002-9276-2306
Electra D PaskettCollege of Public Health, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-8247-8299
Annie-Laurie McReeDivision of General Pediatrics and Adolescent Health, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota.ORCID 0000-0001-6588-5995
Ohio Department of Health · USAdolescent Health Clinic · USCenter for Scientific Review · USUniversity of Pennsylvania · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
A Randomized Controlled Trial of an HPV Vaccine Intervention for Young Sexual Minority MenR37CA226682 · NCI · OHIO STATE UNIVERSITY · PI REITER, PAUL L · 2018 to 2023
$3.1M
NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA046592NCI NIH HHS R37 CA226682
6 · The paper itself

Abstract

backgroundRoutine human papillomavirus (HPV) vaccination is recommended for young adults, yet many young gay, bisexual, and other men who have sex with men (YGBMSM) remain unvaccinated. We report the efficacy of Outsmart HPV, a web-based HPV vaccination intervention for YGBMSM.

methodsFrom 2019 to 2021, we recruited YGBMSM in the United States who were ages 18-25 and unvaccinated against HPV (n = 1,227). Participants were randomized to receive either: (i) Outsmart HPV content online and monthly interactive text reminders (interactive group); (ii) Outsmart HPV content online and monthly unidirectional text reminders (unidirectional group); or (iii) standard information online about HPV vaccine (control group). Regression models compared study groups on HPV vaccination outcomes.

resultsOverall, 33% of participants reported initiating the HPV vaccine series and 7% reported series completion. Initiation was more common among participants in the interactive group compared with the control group [odds ratio (OR) = 1.47, 98.3% confidence interval (CI): 1.03-2.11]. Completion was more common among participants in both the interactive group (OR = 3.70, 98.3% CI: 1.75-7.83) and unidirectional group (OR = 2.26, 98.3% CI: 1.02-5.00) compared with the control group. Participants who received Outsmart HPV content reported higher levels of satisfaction with online content compared with the control group.

conclusionsOutsmart HPV is an efficacious and acceptable HPV vaccination intervention for YGBMSM. Future efforts are needed to determine how to optimize the intervention and disseminate it to settings that provide services to YGBMSM. IMPACT: Outsmart HPV is a promising tool for increasing HPV vaccination among YGBMSM with the potential for wide dissemination.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesSexual and Gender MinoritiesAdolescentAdultHomosexuality, MaleHumansMaleUnited StatesVaccinationYoung AdultPapillomavirus Vaccines

Identifiers

PMID36958851
PMCPMC10239352
OpenAlexW4360602820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.